Procoagulant activity and phosphatidylserine of amniotic fluid cells

 

 Buy Article Permissions and Reprints

Summary

Amniotic fluid (AF) may induce disseminated intravascular coagulation (DIC) when it enters maternal circulation by breaching the placental-maternal circulation barrier. The precise mechanism of the procoagulant activity of AF is unclear, but tissue factor (TF) has been proposed to be the main cause. As one constituent of AF, AF cells accumulate and undergo apoptosis continuously. Therefore, we speculate that AF cells have procoagulant activity due to the externalisation of phosphatidylserine (PS). The present study aims to demonstrate that, in addition to TF, the PS that is externalised on AF cells is important for the procoagulant activity of AF. Ten AF samples from parturient women were analysed using lactadherin as the probe for PS. Anti-TF antibody also was used to identify TF and its associated coagulation functions in AF cells. Normal platelets, neutrophils, and lymphocytes were harvested as controls. Confocal microscopy and flow cytometry was used to assess PS expression on AF cells. The procoagulant activity of AF cells was demonstrated by a plasma coagulation assay and further confirmed by factor Xase/prothrombinase assays. PS and TF were present on most AF cells, providing substantial procoagulant activity. Furthermore, factor Xase and prothrombinase assays showed that AF cells substantially enforced the activation of factor X and prothrombin. PS on AF cells is an important procoagulant source for AF. Lactadherin is an ideal anticoagulant for inhibiting the procoagulant activity of AF cells.

• References

• 1 Benson MD. A hypothesis regarding complement activation and amniotic fluid embolism. Med Hypotheses 2007; 68: 1019-1025.
  CrossrefPubMedGoogle Scholar
• 2 Phillips LL, Davidson EC. Procoagulant properties of amniotic fluid. Am J Obstet Gynecol 1972; 113: 911-919.
  CrossrefPubMedGoogle Scholar
• 3 Clark SL, Hankins GD, Dudley DA. et al. Amniotic fluid embolism: Analysis of the national registry. Am J Obstet Gynecol 1995; 172: 1158-1167.
  CrossrefPubMedGoogle Scholar
• 4 Harnett MJ, Hepner DL, Datta S. et al. Effect of amniotic fluid on coagulation and platelet function in pregnancy: An evaluation using thromboelastography. Anaesthesia 2005; 60: 1068-1072.
  CrossrefPubMedGoogle Scholar
• 5 Awad IT, Shorten GD. Amniotic fluid embolism and isolated coagulopathy: Atypical presentation of amniotic fluid embolism. Eur J Anaesthesiol 2001; 18: 410-413.
  CrossrefPubMedGoogle Scholar
• 6 Tydén O, Bergström S, Nilsson BA. Origin of amniotic cells in mid-tremester pregnancies. Br J Obstet Gynaecol 1981; 88: 278-286.
  CrossrefPubMedGoogle Scholar
• 7 Bombeli T, Karsan A, Tait JF. et al. Apoptotic vascular endothelial cells become procoagulant. Blood 1997; 89: 2429-2442.
  PubMedGoogle Scholar
• 8 Solum NO. Procoagulant expression in platelets and defects leading to clinical disorders. Arterioscler Thromb Vasc Biol 1999; 19: 2841-2846.
  CrossrefPubMedGoogle Scholar
• 9 Vance JE, Steenbergen R. Metabolism and functions of phosphatidylserine. Proq Lipid Res 2005; 44: 207-234.
  PubMedGoogle Scholar
• 10 Østerud B, Bjorklid E. The tissue factor pathway in disseminated intravascular coagulation. Semin Thromb Hemost 2001; 27: 605-617.
  Article in Thieme ConnectPubMedGoogle Scholar
• 11 Stubbs JD, Lekutis C, Singer KL. et al. cDNA cloning of a mouse mammary epithelial cell surface protein reveals the existence of epidermal growth factor-like domains linked to factor VIII-like sequences. Proc Natl Acad Sci USA 1990; 87: 8417-8421.
  CrossrefPubMedGoogle Scholar
• 12 Shi J, Heegaard CW, Rasmussen JT. et al. Lactadherin binds selectively to membranes containing phosphatidyl-L-serine and increased curvature. Biochim Biophys Acta 2004; 1667: 82-90.
  CrossrefPubMedGoogle Scholar
• 13 Shi J, Gilbert GE. Lactadherin inhibits enzyme complexes of blood coagulation by competing for phospholipid-binding sites. Blood 2003; 101: 2628-2636.
  CrossrefPubMedGoogle Scholar
• 14 Dasgupta SK, Guchhait P, Thiagarajan P. Lactadherin binding and phosphatidylserine expression on cell surface-comparison with annexin A5. Transl Res 2006; 148: 19-25.
  CrossrefPubMedGoogle Scholar
• 15 Hvarregaard J, Andersen MH, Berglund L. et al. Characterization of glycoprotein PAS-6/7 from membranes of bovine milk fat globules. Eur J Biochem 1996; 240: 628-636.
  CrossrefPubMedGoogle Scholar
• 16 Kim DH, Kanno C, Mizokami Y. Purification and characterization of major glycoproteins, PAS-6 and PAS-7, from bovine milk fat globule membrane. Biochim Biophys Acta 1992; 1122: 203-211.
  CrossrefPubMedGoogle Scholar
• 17 Uszyzski M, Zekanowska E, Uszyzski W. et al. Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in amniotic fluid and blood plasma: implications for the mechanism of amniotic fluid embolism. Eur J Obstet Gynecol Reprod Biol 2001; 95: 163-166.
  CrossrefPubMedGoogle Scholar
• 18 Kumar D, Fung W, Moore RM. et al. Proinflamma-tory cytokines found in amniotic fluid induce collagen remodeling, apoptosis, and biophysical weakening of cultured human fetal membranes. Biol Reprod 2006; 74: 29-34.
  CrossrefPubMedGoogle Scholar
• 19 Bombeli T, Karsan A, Tait JF. et al. Apoptotic vascular endothelial cells become procoagulant. Blood 1997; 89: 2429-2442.
  PubMedGoogle Scholar
• 20 Gilbert GE, Furie BC, Furie B. Binding of human factor VIII to phospholipid vesicles. J Biol Chem 1990; 265: 815-822.
  PubMedGoogle Scholar
• 21 Gilbert GE, Arena AA. Activation of the factor VIIIa-factor IXa enzyme complex of blood coagulation by membranes containing phosphatidyl-L-serine. J Biol Chem 1996; 271: 11120-11125.
  CrossrefPubMedGoogle Scholar
• 22 Majumder R, Weinreb G, Lentz BR. Efficient thrombin generation requires molecular phosphatidylserine, not a membrane surface. Biochemistry 2005; 44: 16998-17006.
  CrossrefPubMedGoogle Scholar
• 23 Majumder R, Quinn-Allen MA, Kane WH. et al. The phosphatidylserine binding site of the factor Va C2 domain accounts for membrane binding but does not contribute to the assembly or activity of a human factor Xa-factor Va complex. Biochemistry 2005; 44: 711-718.
  CrossrefPubMedGoogle Scholar
• 24 Gale AJ, Yegneswaran S, Xu X. et al. Characterization of a factor Xa binding site on factor Va near the Arg-506 activated protein C cleavage site. J Biol Chem 2007; 282: 21848-21855.
  CrossrefPubMedGoogle Scholar
• 25 Majumder R, Weinreb G, Zhai X. et al. Soluble phosphatidylserine triggers assembly in solution of a prothrombin-activating complex in the absence of a membrane surface. J Biol Chem 2002; 277: 29765-29773.
  CrossrefPubMedGoogle Scholar
• 26 Wang J, Weiss I, Svoboda K. et al. Thrombogenic role of cells undergoing apoptosis. Br J Haemotol 2001; 115: 382-391.
  CrossrefPubMedGoogle Scholar
• 27 Lockwood CJ, Bach R, Guha A. et al. Amniotic fluid contains tissue factor, a potent initiator of coagulation. Am J Obstet Gynecol 1991; 165: 1335-1341.
  CrossrefPubMedGoogle Scholar
• 28 Fujii M, Hayakawa H, Urano T. et al. Relevance of tissue factor and tissue factor pathway inhibitor for hypercoagulable state in the lungs of patients with idiopathic pulmonary fibrosis. Thromb Res 2000; 99: 111-117.
  CrossrefPubMedGoogle Scholar
• 29 Lurie S, Feinstein M, Mamet Y. Disseminated intravascular coagulopathy in pregnancy: Thorough comprehension of etiology and management reduces obstetricians’ stress. Arch Gynecol Obstet 2000; 263: 126-130.
  CrossrefPubMedGoogle Scholar
• 30 Uszyzski W, Uszyzski M, Zekanowska E. Thrombin activatable fibrinolysis inhibitor (TAFI) in human amniotic fluid. A preliminary study. Thromb Res 2007; 119: 241-245.
  CrossrefPubMedGoogle Scholar
• 31 Uszyzski M, Zekanowska E, Kotzbach M. et al. Protein C, protein S, and thrombomodulin in amniotic fluid. A preliminary study. J Perinat Med 2006; 34: 289-292.
  PubMedGoogle Scholar